Primary cutaneous B-cell lymphomas with large cell predominance–primary cutaneous follicle center lymphoma, diffuse large B-cell lymphoma, leg type and intravascular large B-cell lymphoma-Reference-Cited by-同舟云学术

Primary cutaneous B-cell lymphomas with large cell predominance–primary cutaneous follicle center lymphoma, diffuse large B-cell lymphoma, leg type and intravascular large B-cell lymphoma

Published:2017-01 Issue:1 Volume:34 Page:85-98
ISSN:0740-2570
Container-title:Seminars in Diagnostic Pathology
language:en
Short-container-title:Seminars in Diagnostic Pathology

Author:

Hope Charity B.,Pincus Laura B.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference129 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms;Swerdlow;Blood.,2016

2. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer;Willemze;Blood.,1997

3. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients;Fink-Puches;Blood,2002

4. WHO-EORTC classification for cutaneous lymphomas;Willemze;Blood,2005

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. THE UTILITY OF THE NORMAL THIN SECTION SKIN BIOPSY IN THE ASSESSMENT OF SYSTEMIC/EXTRACUTANEOUS DISEASE;Clinics in Dermatology;2024-09

2. A unique case of a lymphoproliferative disorder affecting the skin and uterine cervix on a male transgender;Anais Brasileiros de Dermatologia;2024-01

3. CD5+ Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Presenting as an Asymptomatic Nodule;Hematology Reports;2023-09-01

4. Violaceous Lesions on the Leg: What Else Apart from Kaposi Sarcoma? Differential Diagnosis with a Narrative Review of the Literature;Dermato;2023-02-16

5. Cost-effectiveness analysis of axicabtagene ciloleucel as a second-line treatment for diffuse large B-cell lymphoma in China and the United States;Therapeutic Advances in Hematology;2023-01